PICALM-MLLT10 acute myeloid leukemia: A French cohort of 18 patients

Leukemia Research

Volumn 36, Issue 11, 2012, Pages 1365-1369

  Borel, Cecile ^a   Dastugue, Nicole ^a   Cances Lauwers, Valérie ^a   Mozziconacci, Marie Joelle ^c   Prebet, Thomas ^c   Vey, Norbert ^c   Pigneux, Aranud ^d   Lippert, Eric ^e   Visanica, Sorin ^f   Legrand, Faezeh ^g   Rault, Jean Philippe ^f   Taviaux, Sylvie ^h   Bastard, Christian ⁱ   Mugneret, Francine ^j   Collonges Rames, Marie Agnes ^k   Gachard, Nathalie ^l   Talmant, Pascaline ^m   Delabesse, Eric ^a,b   Récher, Christian ^a,b  

^a CHU PURPAN   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e HÔPITAL PELLEGRIN   (France)

^f CHR Metz   (France)

^g Hopital de Besancon   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE HENRI BECQUEREL   (France)

^j DIJON UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF BESANÇON   (France)

^l LIMOGES UNIVERSITY HOSPITAL   (France)

^m NANTES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Acute myeloid leukemia; PICALM MLLT10; T(10; 11); Therapy related acute leukemia

Indexed keywords

BLEOMYCIN; CARMUSTINE; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; MITOGUAZONE; NAVELBINE; PREDNISONE; RITUXIMAB; VINCRISTINE; VINDESINE;

ABDOMINAL MASS; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FRANCE; FUSION GENE; GENE REARRANGEMENT; GINGIVA HYPERTROPHY; GRANULOCYTIC SARCOMA; HEPATOSPLENOMEGALY; HUMAN; LARGE CELL LYMPHOMA; LOW DRUG DOSE; MALE; MEDIASTINUM MASS; OVERALL SURVIVAL; PICALM MLLT10 FUSION GENE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHILD; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866334323     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.07.008     Document Type: Article

References (11)

1. Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D., Bohlander S.K. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci U S A 1996, 93:4804-4809.
2. Kumon K., Kobayashi H., Maseki N., Sakashita A., Sakurai M., Tanizawa A., et al. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes Cancer 1999, 25:33-39.
3. Bacher U., Kern W., Schnittger S., Hiddemann W., Haferlach T., Schoch C. Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica 2005, 90:1502-1510.
4. Grimwade D., Hills R.K., Moorman A.V., Walker H., Chatters S., Goldstone A.H., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010, 116:354-365.
5. An international system for human cytogenetic nomenclature 2009, L.G. Shaffer, M.L.S.L.J. Campbell (Eds.).
6. Chevallier P., Fornecker L., Lioure B., Béné M.C., Pigneux A., Recher C., et al. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial. Leukemia 2011, 24:1380-1385.
7. Castaigne S., Chevret S., Archimbaud E., Fenaux P., Bordessoule D., Tilly H., et al. Randomized comparison of double induction and timed-sequential induction to a "3+7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study. Blood 2004, 104:2467-2474.
8. Jourdan E., Rigal-Huguet F., Marit G., Vey N., Dastugue N., Fegueux N., et al. One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission. Br J Haematol 2005, 129:403-410.
9. Cheson B.D., Bennett J.M., Kopecky K.J., Büchner T., Willman C.L., Estey E.H., et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria. Treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003, 21:4642-4649.
10. André M., Mounier N., Leleu X., Sonet A., Brice P., Henry-Amar M., et al. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients. Blood 2004, 103:1222-1228.
11. Borel C., Huynh A., Chaufour X., Lousteau O., Demur C., Delabesse E., et al. Uterine chloroma, aortic thrombus and CALM/AF10 acute myeloid leukemia. Leuk Res 2011, 34:e88-e90.